RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BLCM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Bellicum Pharmaceuticals
(Updated on Mar 27, 2024)

Hold candidate since Mar 06, 2024 PDF

No changes to the price of Bellicum Pharmaceuticals stock on the last trading day (Wednesday, 27th Mar 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0857 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -44.56% during the next 3 months and, with a 90% probability hold a price between $0.0168 and $0.0475 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BLCM Signals & Forecast

There are mixed signals in the stock today. The Bellicum Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0748 and $0.0800. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Monday, March 04, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation

Support, Risk & Stop-loss for Bellicum Pharmaceuticals stock

Bellicum Pharmaceuticals finds support from accumulated volume at $0.0745 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0703 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 17 days ago.)

Trading Expectations (BLCM) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Bellicum Pharmaceuticals to open at $0.0748, and during the day (based on 14 day Average True Range), to move between $0.0703 and $0.0792, which gives a possible trading interval of +/-$0.0044 (+/-5.94%) up or down from last closing price. If Bellicum Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 11.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0745 (0.33%) than the resistance at $0.0755 (1.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bellicum Pharmaceuticals stock A Buy?

Bellicum Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Bellicum Pharmaceuticals of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.0748 ( 0%) $0.0748

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BLCM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0748 .
R2 0.0748 .
R1 0.0748 .
Current price: 0.0748
Support S1 0.0748 .
S2 0.0748 .
S3 0.0748 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0900 20.40 %
R2 0.0810 8.36 %
R1 0.0755 1.00 %
Current price 0.0748
Support S1 0.0745 -0.334%
S2 0 .
S3 0 .

FAQ

What is the symbol for Bellicum Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Bellicum Pharmaceuticals is BLCM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bellicum Pharmaceuticals Stock?
Bellicum Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Bellicum Pharmaceuticals Stock?
Bellicum Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bellicum Pharmaceuticals Stock.

What's the current price of Bellicum Pharmaceuticals Stock?
As of the end of day on the 2024-03-27, the price of an Bellicum Pharmaceuticals (BLCM) share was $0.0748.

What is the 52-week high and low for Bellicum Pharmaceuticals Stock?
The 52-week high for Bellicum Pharmaceuticals Stock is $1.31 and the 52-week low is $0.0600.

What is the market capitalization of Bellicum Pharmaceuticals Stock?
As of the 2024-03-27, the market capitalization of Bellicum Pharmaceuticals is 778.326K.

When is the next earnings date for Bellicum Pharmaceuticals?
The upcoming earnings date for Bellicum Pharmaceuticals is Mar 29, 2024.
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT